These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1524702)

  • 1. A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.
    Chevalier X; Albengres E; Voisin MC; Tillement JP; Larget-Piet B
    Drug Saf; 1992; 7(4):310-4. PubMed ID: 1524702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
    Kesseler A; Lacassie A; Hugot JP; Talon P; Thomas D; Astier L
    Ann Pediatr (Paris); 1989 Apr; 36(4):275-8. PubMed ID: 2742312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe polyarthropathy in an adolescent treated with pefloxacin.
    Le Loët X; Fessard C; Noblet C; Ait Saït L; Moore N
    J Rheumatol; 1991 Dec; 18(12):1941-2. PubMed ID: 1795342
    [No Abstract]   [Full Text] [Related]  

  • 4. Pefloxacin-induced arthropathy in an adolescent with brain abscess.
    Chang H; Chung MH; Kim JH; Kim JH
    Scand J Infect Dis; 1996; 28(6):641-3. PubMed ID: 9060073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Joint manifestations of pefloxacin in adolescents].
    Seigneuric C; Plantavid M; Bouygues D; Cassou M; Amar J; Cascarigny F
    Presse Med; 1990 Mar; 19(9):428. PubMed ID: 2138767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arthropathy caused by pefloxacin. Report of a case. Histologic study of the synovia].
    Ollier S; Laroche M; Arlet P; Montane P; Durroux R; Le Tallec Y
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):671. PubMed ID: 2075409
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arthropathy with achilles tendon involvement induced by pefloxacin. Apropos of a case].
    Jorgensen C; Anaya JM; Didry C; Canovas F; Serre I; Baldet P; Ribard P; Kahn MF; Sany J
    Rev Rhum Mal Osteoartic; 1991 Oct; 58(9):623-5. PubMed ID: 1775911
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoroquinolones in children: poorly defined risk of joint damage.
    Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side-effects of pefloxacin in idiopathic nephrotic syndrome.
    Aigrain EJ; Brun P; Bennasr S; Loirat C
    Lancet; 1993 Aug; 342(8868):438-9. PubMed ID: 8101937
    [No Abstract]   [Full Text] [Related]  

  • 10. [Polyarthropathy in an adolescent treated with pefloxacin].
    Chaslerie A; Bannwarth B; Fillol M; Joussein M; Laborde-Laulhe AM; Begaud B
    Therapie; 1992; 47(1):80. PubMed ID: 1523601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Joint tolerance of pefloxacin and ofloxacin in children and adolescents with cystic fibrosis].
    Pertuiset E; Lenoir G; Jehanne M; Douchain F; Guillot M; Menkès CJ
    Rev Rhum Mal Osteoartic; 1989 Nov; 56(11):735-40. PubMed ID: 2692134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of joint toxicity from pefloxacin in the treatment of nephrotic syndrome in a child].
    Diouf B; Djoneidi M; Niang A; Diallo S; Moreira-Diop T; Bao O
    Dakar Med; 1996; 41(2):105-7. PubMed ID: 9827103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific toxicologic aspects of the quinolones.
    Christ W; Lehnert T; Ulbrich B
    Rev Infect Dis; 1988; 10 Suppl 1():S141-6. PubMed ID: 3279489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of congenital insensitivity to pain with destructive arthropathies of the limbs and spine. Discussion on nosology and physiopathology of the disease].
    Le Parc JM; Brunod V; Paolaggi JB; Auquier L
    Ann Med Interne (Paris); 1985; 136(8):650-4. PubMed ID: 2421625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin].
    Andrejak M; Schmit JL; Tondriaux A; Hary L; Debailleux S; Moore N
    Therapie; 1992; 47(5):415-8. PubMed ID: 1299981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An acute psychotic disorder caused by pefloxacin: a case report.
    Hesslinger B; Hellwig B; Sester U; Walden J; Berger M
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Feb; 20(2):343-7. PubMed ID: 8861197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity anaphylactoid reaction to pefloxacin in a patient with AIDS.
    al-Hedaithy MA; Noreddin AM
    Ann Pharmacother; 1996 Jun; 30(6):612-4. PubMed ID: 8792948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.
    Chevais M; Reinert P; Rondeau MC; Tobelem R; Albengres E; Riant P; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):306-9. PubMed ID: 3476471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombopenia due to pefloxacin (Peflacine): dose-dependent toxicity?].
    Chichmanian RM; Spreux A; Bernard E; Garraffo R; Fuzibet JG
    Therapie; 1992; 47(5):419-21. PubMed ID: 1299982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.